5QO Stock Overview
Provides visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Qlucore AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.64 |
| 52 Week High | kr1.09 |
| 52 Week Low | kr0.48 |
| Beta | 0.42 |
| 1 Month Change | -3.05% |
| 3 Month Change | 10.43% |
| 1 Year Change | -41.74% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5QO | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 13.4% | 4.1% | 0.6% |
| 1Y | -41.7% | -25.2% | 5.4% |
Return vs Industry: 5QO underperformed the German Healthcare Services industry which returned -24.1% over the past year.
Return vs Market: 5QO underperformed the German Market which returned 7.3% over the past year.
Price Volatility
| 5QO volatility | |
|---|---|
| 5QO Average Weekly Movement | 9.9% |
| Healthcare Services Industry Average Movement | 4.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 5QO has not had significant price volatility in the past 3 months.
Volatility Over Time: 5QO's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 22 | Carl-Johan Ivarsson | www.qlucore.com |
Qlucore AB (publ) provides visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a software platform for multi-omics companion. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Qlucore AB (publ) Fundamentals Summary
| 5QO fundamental statistics | |
|---|---|
| Market cap | €2.73m |
| Earnings (TTM) | -€1.29m |
| Revenue (TTM) | €3.41m |
0.8x
P/S Ratio-2.1x
P/E RatioIs 5QO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5QO income statement (TTM) | |
|---|---|
| Revenue | kr39.73m |
| Cost of Revenue | kr29.42m |
| Gross Profit | kr10.31m |
| Other Expenses | kr25.38m |
| Earnings | -kr15.07m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | -3.74 |
| Gross Margin | 25.95% |
| Net Profit Margin | -37.93% |
| Debt/Equity Ratio | 4.2% |
How did 5QO perform over the long term?
See historical performance and comparison